This healthcare giant is trading at a discounted price today.
Is PFE a good stock to buy now? We came across a bullish thesis on Pfizer Inc. on Investomine’s Substack. In this article, we ...
Zacks Investment Research on MSN
PFE vs BMY: Which large oncology drugmaker is a better pick now?
Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast a dominant position in the lucrative oncology space. Oncology or ...
If you are wondering whether Pfizer's current share price reflects its long term potential or lingering concerns, looking ...
Pfizer (PFE) looks undervalued at 8–9x forward earnings with a ~7% yield; see how Seagen, cost cuts and the pipeline could ...
Pfizer (PFE) remains in focus for income oriented investors, with recent returns ranging from a 2.1% decline over the past ...
Right now, Pfizer's dividend payout ratio is above 100%. That suggests the dividend comes with some risk, which is true.
Pfizer Inc. (NYSE:PFE) is one of Goldman Sachs top healthcare stocks. On March 9, analysts at BMO reiterated an Outperform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results